×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Alpine Immune Sciences Inc. (ALPN) NASDAQ

$64.97 0.01 (0.01%)

Market Cap: -

As of 05/17/24 04:00 PM EDT. Market closed.

(ALPN)

Alpine Immune Sciences Inc. (ALPN)
NASDAQ

$64.97
0.01 (0.01%)

Market Cap: -

As of 05/17/24 04:00 PM EDT. Market closed.

Add to Portfolio

founded in 2015 by a team responsible for the fda's approval of the world's first cancer immunotherapy and experts in the field of recombinant protein based immunotherapies, alpine immune sciences was created to capitalize on our unique understanding of immunology, modifying the complexities of the immune synapse for the benefit of patients living with cancer, autoimmune disorders, and other ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
URL
Address
600 Stewart St Ste 1503, Washington, Seattle, 98101-1291.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Mitchell Gold
URL
Address
600 Stewart St Ste 1503, Washington, Seattle, 98101-1291.
PRICE CHART FOR ALPINE IMMUNE SCIENCES INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$64.96
Days Range
$64.97 - $65
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
68,597,527
Open
-
Previous Close
$64.96
Days Range
$64.97 - $65
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
68,597,527
FINANCIAL STATEMENTS FOR ALPINE IMMUNE SCIENCES INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ALPINE IMMUNE SCIENCES INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
PENG STANFORD LSee RemarksMay 08, 2024 Option Exercise$2.46271,792669,403344,163May 10, 2024, 07:26 PM
DURAND REMYChief Business OfficerMay 08, 2024 Option Exercise$5.3995,288513,869133,392May 10, 2024, 07:25 PM
GOLD MITCHELLExecutive Chairman and CEOMay 08, 2024 Option Exercise$7.5513,245100,000109,245May 10, 2024, 07:24 PM
FUHS ULRICH MARTINChief Accounting OfficerMay 08, 2024 Option Exercise$12.0722,820275,43730,120May 10, 2024, 07:22 PM
Rickey James PaulSee RemarksMay 07, 2024 Option Exercise$6.0426,761161,62957,961May 09, 2024, 09:13 PM
Topper James NDirectorApr 25, 2024 Sale$64.57191,2272,829,347Apr 29, 2024, 04:32 PM
Topper James NDirectorApr 25, 2024 Option Exercise$0.001,200,0001,2002,829,366Apr 29, 2024, 04:32 PM
Rickey James PaulSee RemarksJan 25, 2024 Option Exercise$6.512361,536236Jan 29, 2024, 07:04 PM
Rickey James PaulSee RemarksJan 26, 2024 Option Exercise$8.30117,764977,84473,764Jan 29, 2024, 07:04 PM
Rickey James PaulSee RemarksJan 26, 2024 Sale$23.32117,7642,745,8300Jan 29, 2024, 07:04 PM
Rickey James PaulSee RemarksJan 25, 2024 Sale$22.002365,1920Jan 29, 2024, 07:04 PM
Decheng Capital China Life Sciences USD Fund III, L.P.10% OwnerJan 18, 2024 Option Exercise$12.741,234,63615,729,2626,582,380Jan 22, 2024, 06:54 PM
Cui XiangminDirectorJan 18, 2024 Option Exercise$12.741,234,63615,729,2626,582,380Jan 22, 2024, 05:48 PM
ORBIMED ADVISORS LLCDirectorJan 11, 2024 Option Exercise$12.74145,2511,850,4982,416,181Jan 16, 2024, 04:39 PM
Thompson Peter A.DirectorJan 11, 2024 Option Exercise$12.74145,2511,850,4982,416,181Jan 16, 2024, 04:36 PM
GOLD MITCHELLExecutive Chairman and CEODec 28, 2023 Option Exercise$19.6548,264948,3882,627,157Dec 29, 2023, 07:32 PM
GOLD MITCHELLExecutive Chairman and CEODec 28, 2023 Option Exercise$0.651,0166601,016Dec 29, 2023, 07:32 PM
GOLD MITCHELLExecutive Chairman and CEODec 28, 2023 Option Exercise$12.7474,441948,3782,675,421Dec 29, 2023, 07:32 PM
GOLD MITCHELLExecutive Chairman and CEODec 28, 2023 Sale$20.041,01620,3620Dec 29, 2023, 07:32 PM
Thompson Peter A.DirectorDec 28, 2023 Sale$18.351,364,84925,049,0333,466,613Dec 29, 2023, 04:20 PM
Thompson Peter A.DirectorDec 27, 2023 Sale$19.96181,4983,622,7003,493,485Dec 29, 2023, 04:20 PM
ORBIMED ADVISORS LLCDirectorDec 28, 2023 Sale$18.351,364,84925,049,0333,466,613Dec 29, 2023, 04:18 PM
ORBIMED ADVISORS LLCDirectorDec 27, 2023 Sale$19.96181,4983,622,7003,493,485Dec 29, 2023, 04:18 PM
GOLD MITCHELLExecutive Chairman and CEODec 27, 2023 Option Exercise$0.6529,57319,22229,573Dec 27, 2023, 09:07 PM
GOLD MITCHELLExecutive Chairman and CEODec 26, 2023 Option Exercise$0.6324,48615,43524,486Dec 27, 2023, 09:07 PM
GOLD MITCHELLExecutive Chairman and CEODec 22, 2023 Option Exercise$0.4537,82517,02137,825Dec 27, 2023, 09:07 PM
GOLD MITCHELLExecutive Chairman and CEODec 26, 2023 Sale$20.2224,486495,2170Dec 27, 2023, 09:07 PM
GOLD MITCHELLExecutive Chairman and CEODec 22, 2023 Sale$20.4337,825772,5950Dec 27, 2023, 09:07 PM
GOLD MITCHELLExecutive Chairman and CEODec 27, 2023 Sale$20.0429,573592,7170Dec 27, 2023, 09:07 PM
Rickey James PaulSee RemarksDec 19, 2023 Option Exercise$5.0215,21376,36915,213Dec 21, 2023, 07:35 PM
Rickey James PaulSee RemarksDec 19, 2023 Sale$19.2115,213292,2220Dec 21, 2023, 07:35 PM
GOLD MITCHELLExecutive Chairman and CEODec 19, 2023 Option Exercise$0.452,4021,0812,402Dec 21, 2023, 07:34 PM
GOLD MITCHELLExecutive Chairman and CEODec 19, 2023 Sale$20.012,40248,0640Dec 21, 2023, 07:34 PM
Rickey James PaulSee RemarksDec 15, 2023 Option Exercise$5.0245,387227,84345,387Dec 18, 2023, 09:20 PM
Rickey James PaulSee RemarksDec 14, 2023 Option Exercise$5.0211,60058,23211,600Dec 18, 2023, 09:20 PM
Rickey James PaulSee RemarksDec 18, 2023 Option Exercise$5.021,8009,0361,800Dec 18, 2023, 09:20 PM
Rickey James PaulSee RemarksDec 14, 2023 Sale$19.0011,600220,4060Dec 18, 2023, 09:20 PM
Rickey James PaulSee RemarksDec 18, 2023 Sale$19.001,80034,2030Dec 18, 2023, 09:20 PM
Rickey James PaulSee RemarksDec 15, 2023 Sale$19.0945,387866,3830Dec 18, 2023, 09:20 PM
Topper James NDirectorDec 11, 2023 Option Exercise$12.74145,2511,850,4981,629,366Dec 13, 2023, 05:30 PM
GOLD MITCHELLExecutive Chairman and CEODec 12, 2023 Option Exercise$0.458,6133,8768,613Dec 12, 2023, 09:02 PM
GOLD MITCHELLExecutive Chairman and CEODec 08, 2023 Sale$17.088,067137,784101,320Dec 12, 2023, 09:02 PM
GOLD MITCHELLExecutive Chairman and CEODec 12, 2023 Sale$17.3241,063711,0260Dec 12, 2023, 09:02 PM
GOLD MITCHELLExecutive Chairman and CEODec 11, 2023 Sale$17.2668,8701,189,02732,450Dec 12, 2023, 09:02 PM
Rickey James PaulSee RemarksDec 04, 2023 Option Exercise$3.2363,947206,54963,947Dec 06, 2023, 07:31 PM
Rickey James PaulSee RemarksDec 06, 2023 Option Exercise$3.236,44620,8216,446Dec 06, 2023, 07:31 PM
Rickey James PaulSee RemarksDec 05, 2023 Option Exercise$3.234181,350418Dec 06, 2023, 07:31 PM
Rickey James PaulSee RemarksDec 06, 2023 Sale$16.086,446103,6500Dec 06, 2023, 07:31 PM
Rickey James PaulSee RemarksDec 05, 2023 Sale$16.014186,6940Dec 06, 2023, 07:31 PM
Rickey James PaulSee RemarksDec 04, 2023 Sale$16.0663,9471,026,8860Dec 06, 2023, 07:31 PM
Rickey James PaulSee RemarksNov 30, 2023 Option Exercise$3.237002,261700Dec 01, 2023, 05:00 PM
Rickey James PaulSee RemarksNov 30, 2023 Sale$16.0070011,2000Dec 01, 2023, 05:00 PM
Decheng Capital Global Healthcare Fund (Master), LP10% OwnerNov 09, 2023 Buy$12.50375,0004,687,5001,735,544Nov 14, 2023, 05:36 PM
Cui XiangminDirectorNov 09, 2023 Buy$12.50375,0004,687,5001,735,544Nov 14, 2023, 05:33 PM
Rickey James PaulSee RemarksNov 06, 2023 Option Exercise$3.2310,98935,49418,003Nov 08, 2023, 05:20 PM
Rickey James PaulSee RemarksNov 06, 2023 Sale$16.0318,003288,5540Nov 08, 2023, 05:20 PM
Cui XiangminDirectorSep 23, 2022 Option Exercise$7.352,000,00014,700,0005,347,744Sep 27, 2022, 04:51 PM
Decheng Capital China Life Sciences USD Fund III, L.P.10% OwnerSep 23, 2022 Option Exercise$7.351,360,5449,999,9981,360,544Sep 27, 2022, 04:46 PM
Decheng Capital China Life Sciences USD Fund III, L.P.10% OwnerSep 23, 2022 Option Exercise$7.35639,4564,700,0025,347,744Sep 27, 2022, 04:46 PM
Venkatesan JayDirectorJul 15, 2022 Option Exercise$0.4520,0639,028238,126Jul 19, 2022, 04:38 PM
Frazier Life Sciences VIII, L.P.10% OwnerFeb 11, 2022 Buy$7.10112,665799,9891,484,115Feb 15, 2022, 05:00 PM
Peetz ChristopherDirectorSep 23, 2021 Buy$10.171,90019,3231,900Sep 27, 2021, 07:03 AM
CONWAY ROBERT EDirectorSep 23, 2021 Buy$10.0815,000151,15350,000Sep 27, 2021, 07:02 AM
CONWAY ROBERT EDirectorSep 23, 2021 Sale$10.0815,000151,15350,000Sep 24, 2021, 06:39 PM
Peetz ChristopherDirectorSep 23, 2021 Sale$10.171,90019,3231,900Sep 24, 2021, 05:32 PM
CONWAY ROBERT EDirectorSep 21, 2021 Buy$9.8010,00097,96635,000Sep 23, 2021, 08:31 PM
ORBIMED ADVISORS LLCDirectorSep 17, 2021 Buy$9.401,010,6379,499,9873,656,061Sep 21, 2021, 06:42 PM
Decheng Capital China Life Sciences USD Fund III, L.P.10% OwnerSep 17, 2021 Buy$9.401,542,55314,499,9984,708,288Sep 21, 2021, 06:39 PM
Thompson Peter A.DirectorSep 17, 2021 Buy$9.401,010,6379,499,9873,656,061Sep 21, 2021, 06:38 PM
Alpine ImmunoSciences, L.P.10% OwnerSep 17, 2021 Sale$9.40400,0003,760,0002,600,980Sep 21, 2021, 05:18 PM
GOLD MITCHELLExecutive Chairman and CEOSep 17, 2021 Sale$10.0145,262452,964109,387Sep 21, 2021, 05:16 PM
GOLD MITCHELLExecutive Chairman and CEOSep 17, 2021 Sale$9.40400,0003,760,0002,600,980Sep 21, 2021, 05:16 PM
Venkatesan JayDirectorSep 17, 2021 Sale$9.40400,0003,760,0002,600,980Sep 21, 2021, 05:14 PM
Cui XiangminDirectorSep 17, 2021 Buy$9.401,542,55314,499,9984,708,288Sep 21, 2021, 05:12 PM
GOLD MITCHELLExecutive Chairman and CEOSep 15, 2021 Sale$10.003,48434,840161,417Sep 17, 2021, 06:06 PM
GOLD MITCHELLExecutive Chairman and CEOSep 16, 2021 Sale$10.006,76867,696154,649Sep 17, 2021, 06:06 PM
GOLD MITCHELLExecutive Chairman and CEOJun 28, 2021 Sale$10.003,47934,792164,901Jun 29, 2021, 05:13 PM
GOLD MITCHELLExecutive Chairman and CEOJun 25, 2021 Sale$10.019,47394,865168,380Jun 29, 2021, 05:13 PM
GOLD MITCHELLExecutive Chairman and CEOMay 20, 2021 Sale$15.001,22118,316177,853May 21, 2021, 05:16 PM
GOLD MITCHELLExecutive Chairman and CEOMay 19, 2021 Sale$15.0350,965765,917179,074May 21, 2021, 05:16 PM
Venkatesan JayDirectorMar 31, 2021 Option Exercise$3.627,65027,718218,063Apr 23, 2021, 06:14 PM
Venkatesan JayDirectorMar 30, 2021 Option Exercise$4.097,65031,289210,413Apr 23, 2021, 06:14 PM
GOLD MITCHELLExecutive Chairman and CEOApr 14, 2021 Sale$10.5210,000105,200250,039Apr 15, 2021, 06:09 PM
GOLD MITCHELLExecutive Chairman and CEOApr 13, 2021 Sale$10.0710,000100,714260,039Apr 15, 2021, 06:09 PM
GOLD MITCHELLExecutive Chairman and CEOMar 05, 2021 Sale$12.9910,000129,875270,039Mar 08, 2021, 05:01 PM
GOLD MITCHELLExecutive Chairman and CEOMar 04, 2021 Sale$13.0110,000130,108280,039Mar 08, 2021, 05:01 PM
GOLD MITCHELLExecutive Chairman and CEOFeb 02, 2021 Sale$11.7410,000117,381290,039Feb 03, 2021, 05:01 PM
GOLD MITCHELLExecutive Chairman and CEOFeb 01, 2021 Sale$12.8710,000128,665307,060Feb 03, 2021, 05:01 PM
PENG STANFORD LSee RemarksDec 31, 2020 Option Exercise$12.603,92349,43024,371Jan 04, 2021, 08:41 PM
GOLD MITCHELLExecutive Chairman and CEODec 31, 2020 Option Exercise$12.6011,123140,150310,039Jan 04, 2021, 08:37 PM
Rickey James PaulSenior VP and CFODec 31, 2020 Option Exercise$12.602,25828,45124,027Jan 04, 2021, 08:31 PM
ORBIMED ADVISORS LLCDirectorDec 28, 2020 Sale$14.25600,0008,550,0003,070,955Dec 30, 2020, 04:44 PM
Thompson Peter A.DirectorDec 28, 2020 Sale$14.25600,0008,550,0003,070,955Dec 30, 2020, 04:38 PM
CONWAY ROBERT EDirectorNov 19, 2020 Buy$8.0310,00080,30025,000Nov 23, 2020, 05:00 PM
Rickey James PaulSenior VP and CFOJun 30, 2020 Option Exercise$9.712,25821,92526,285Jul 01, 2020, 07:38 PM
GOLD MITCHELLExecutive Chairman and CEOJun 30, 2020 Option Exercise$9.718,22779,88460,634Jul 01, 2020, 07:24 PM
PENG STANFORD LSee RemarksJun 30, 2020 Option Exercise$9.713,92338,09228,294Jul 01, 2020, 07:24 PM
Rickey James PaulSenior VP and CFOMay 30, 2019 Buy$4.9510,00049,50010,000Jun 03, 2019, 08:00 AM
TIGER MANAGEMENT L.L.C.10% OwnerFeb 08, 2019 Sale$5.8525,000146,245137,728Feb 12, 2019, 01:52 PM
Cui XiangminDirectorJan 18, 2019 Option Exercise$5.373,165,73516,999,9973,165,735Jan 23, 2019, 08:48 PM
Thompson Peter A.DirectorJan 18, 2019 Buy$5.37372,4391,999,9973,670,955Jan 23, 2019, 06:01 PM
ORBIMED ADVISORS LLCDirectorJan 18, 2019 Buy$5.37372,4391,999,9973,670,955Jan 23, 2019, 05:58 PM
Alpine ImmunoSciences, L.P.10% OwnerJan 18, 2019 Buy$5.37190,8751,024,9993,994,781Jan 22, 2019, 08:46 PM
GOLD MITCHELLExecutive Chairman and CEOJan 18, 2019 Buy$5.37190,8751,024,9993,994,781Jan 22, 2019, 08:44 PM
Venkatesan JayDirectorJan 18, 2019 Buy$5.37190,8751,024,9993,994,781Jan 22, 2019, 08:44 PM
Frazier Life Sciences VIII, L.P.10% OwnerJan 18, 2019 Buy$5.37372,4391,999,9972,571,450Jan 22, 2019, 05:14 PM
Topper James NDirectorJan 18, 2019 Buy$5.37372,4391,999,9972,571,450Jan 22, 2019, 05:09 PM
BVF PARTNERS L P/IL10% OwnerJun 20, 2017 Buy$2.2517,80640,0641,109,258Jun 22, 2017, 05:08 PM
BVF PARTNERS L P/IL10% OwnerJun 07, 2017 Buy$2.2836,90084,1801,099,526Jun 07, 2017, 06:21 PM
BVF PARTNERS L P/IL10% OwnerJun 05, 2017 Buy$2.2935,75081,8891,079,345Jun 07, 2017, 06:21 PM
BVF PARTNERS L P/IL10% OwnerMay 31, 2017 Buy$2.2528,10063,1411,060,139Jun 01, 2017, 05:11 PM
BVF PARTNERS L P/IL10% OwnerMay 30, 2017 Buy$2.3018,90043,3891,044,789Jun 01, 2017, 05:11 PM
BVF PARTNERS L P/IL10% OwnerMay 17, 2017 Buy$2.3037,37285,9071,011,908May 19, 2017, 06:21 PM
BVF PARTNERS L P/IL10% OwnerMay 19, 2017 Buy$2.3011,60026,6801,034,597May 19, 2017, 06:21 PM
BVF PARTNERS L P/IL10% OwnerMay 18, 2017 Buy$2.3029,88668,7321,028,344May 19, 2017, 06:21 PM
BVF PARTNERS L P/IL10% OwnerMay 11, 2017 Buy$2.347,03416,480986,943May 11, 2017, 06:52 PM
BVF PARTNERS L P/IL10% OwnerMay 10, 2017 Buy$2.3562,000145,433983,149May 11, 2017, 06:52 PM
BVF PARTNERS L P/IL10% OwnerMay 09, 2017 Buy$2.2940,00091,516949,458May 11, 2017, 06:52 PM
CONWAY ROBERT EDirectorMay 08, 2017 Buy$2.2815,00034,20060,000May 11, 2017, 12:17 PM
CONWAY ROBERT EDirectorMay 09, 2017 Buy$2.345,00011,70045,000May 10, 2017, 02:00 PM
TROHA JANICEExec Vice President / COOMay 05, 2017 Buy$2.3410,00023,40010,000May 09, 2017, 02:01 PM
CONWAY ROBERT EDirectorMay 05, 2017 Buy$2.3020,00046,00040,000May 09, 2017, 02:01 PM
CONWAY ROBERT EDirectorMay 04, 2017 Buy$2.2610,00022,60020,000May 08, 2017, 02:00 PM
Rodman David MalcomExec Vice President and CMOJan 04, 2017 Sale$2.276,68715,17911,368Jan 05, 2017, 11:00 AM
Carruthers R MichaelExec Vice President / CFODec 02, 2016 Buy$2.0924,00050,25624,000Dec 05, 2016, 04:26 PM
Rodman David MalcomExec Vice President and CMOOct 04, 2016 Sale$7.965,82046,32712,236Oct 05, 2016, 04:16 PM
Rodman David MalcomExec Vice President and CMOJul 05, 2016 Sale$4.665,95027,72712,105Jul 06, 2016, 04:15 PM
Congleton JonPresident and CEOJun 16, 2016 Buy$3.875,00019,34520,000Jun 17, 2016, 10:51 AM
Congleton JonPresident and CEOMar 24, 2016 Buy$4.225,00021,08415,000Mar 25, 2016, 11:21 AM
Congleton JonPresident and CEOMar 22, 2016 Buy$4.385,00021,90710,000Mar 23, 2016, 04:31 PM
Congleton JonPresident and CEODec 11, 2015 Buy$8.105,00040,5005,000Dec 14, 2015, 12:50 PM
CONWAY ROBERT EDirectorDec 09, 2015 Buy$8.1010,00081,00010,000Dec 11, 2015, 09:01 AM
Flynn James E10% OwnerJun 23, 2015 Buy$14.0077,5391,085,546832,216Jun 25, 2015, 03:14 PM
Flynn James E10% OwnerJun 23, 2015 Buy$14.0067,666947,324726,242Jun 25, 2015, 03:14 PM
Flynn James E10% OwnerJun 23, 2015 Buy$14.00104,7951,467,1301,124,740Jun 25, 2015, 03:14 PM
Rock Springs Capital Management LP10% OwnerJun 22, 2015 Buy$14.00200,0002,800,000564,358Jun 24, 2015, 04:09 PM
Hawkes Bay Master Investors (Cayman) L.P.10% OwnerJun 22, 2015 Buy$14.755,50081,11337,600Jun 23, 2015, 02:11 PM
Hawkes Bay Master Investors (Cayman) L.P.10% OwnerJun 19, 2015 Buy$14.6711,700171,59132,100Jun 23, 2015, 02:11 PM
Jennison Global Healthcare Master Fund, Ltd.10% OwnerJun 22, 2015 Option Exercise$14.00303,6314,250,834329,780Jun 22, 2015, 06:26 PM
Jennison Global Healthcare Master Fund, Ltd.10% OwnerJun 17, 2015 Buy$14.0026,149366,08626,149Jun 19, 2015, 04:55 PM
Hawkes Bay Master Investors (Cayman) L.P.10% OwnerJun 18, 2015 Buy$14.756,20091,45020,400Jun 19, 2015, 01:13 PM
Hawkes Bay Master Investors (Cayman) L.P.10% OwnerJun 17, 2015 Buy$14.3514,200203,82514,200Jun 19, 2015, 01:13 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
PENG STANFORD LSee Remarks05/08/2024669,403
DURAND REMYChief Business Officer05/08/2024513,869
GOLD MITCHELLExecutive Chairman and CEO05/08/2024100,000
FUHS ULRICH MARTINChief Accounting Officer05/08/2024275,437
Rickey James PaulSee Remarks05/07/2024161,629
Topper James NDirector04/25/20241,227
Topper James NDirector04/25/20241,200
Rickey James PaulSee Remarks01/25/20241,536
Rickey James PaulSee Remarks01/26/2024977,844
Rickey James PaulSee Remarks01/26/20242,745,830
Rickey James PaulSee Remarks01/25/20245,192
Decheng Capital China Life Sciences USD Fund III, L.P.10% Owner01/18/202415,729,262
Cui XiangminDirector01/18/202415,729,262
ORBIMED ADVISORS LLCDirector01/11/20241,850,498
Thompson Peter A.Director01/11/20241,850,498
GOLD MITCHELLExecutive Chairman and CEO12/28/2023948,388
GOLD MITCHELLExecutive Chairman and CEO12/28/2023660
GOLD MITCHELLExecutive Chairman and CEO12/28/2023948,378
GOLD MITCHELLExecutive Chairman and CEO12/28/202320,362
Thompson Peter A.Director12/28/202325,049,033
Thompson Peter A.Director12/27/20233,622,700
ORBIMED ADVISORS LLCDirector12/28/202325,049,033
ORBIMED ADVISORS LLCDirector12/27/20233,622,700
GOLD MITCHELLExecutive Chairman and CEO12/27/202319,222
GOLD MITCHELLExecutive Chairman and CEO12/26/202315,435
GOLD MITCHELLExecutive Chairman and CEO12/22/202317,021
GOLD MITCHELLExecutive Chairman and CEO12/26/2023495,217
GOLD MITCHELLExecutive Chairman and CEO12/22/2023772,595
GOLD MITCHELLExecutive Chairman and CEO12/27/2023592,717
Rickey James PaulSee Remarks12/19/202376,369
Rickey James PaulSee Remarks12/19/2023292,222
GOLD MITCHELLExecutive Chairman and CEO12/19/20231,081
GOLD MITCHELLExecutive Chairman and CEO12/19/202348,064
Rickey James PaulSee Remarks12/15/2023227,843
Rickey James PaulSee Remarks12/14/202358,232
Rickey James PaulSee Remarks12/18/20239,036
Rickey James PaulSee Remarks12/14/2023220,406
Rickey James PaulSee Remarks12/18/202334,203
Rickey James PaulSee Remarks12/15/2023866,383
Topper James NDirector12/11/20231,850,498
GOLD MITCHELLExecutive Chairman and CEO12/12/20233,876
GOLD MITCHELLExecutive Chairman and CEO12/08/2023137,784
GOLD MITCHELLExecutive Chairman and CEO12/12/2023711,026
GOLD MITCHELLExecutive Chairman and CEO12/11/20231,189,027
Rickey James PaulSee Remarks12/04/2023206,549
Rickey James PaulSee Remarks12/06/202320,821
Rickey James PaulSee Remarks12/05/20231,350
Rickey James PaulSee Remarks12/06/2023103,650
Rickey James PaulSee Remarks12/05/20236,694
Rickey James PaulSee Remarks12/04/20231,026,886
Rickey James PaulSee Remarks11/30/20232,261
Rickey James PaulSee Remarks11/30/202311,200
Decheng Capital Global Healthcare Fund (Master), LP10% Owner11/09/20234,687,500
Cui XiangminDirector11/09/20234,687,500
Rickey James PaulSee Remarks11/06/202335,494
Rickey James PaulSee Remarks11/06/2023288,554
Cui XiangminDirector09/23/202214,700,000
Decheng Capital China Life Sciences USD Fund III, L.P.10% Owner09/23/20229,999,998
Decheng Capital China Life Sciences USD Fund III, L.P.10% Owner09/23/20224,700,002
Venkatesan JayDirector07/15/20229,028
Frazier Life Sciences VIII, L.P.10% Owner02/11/2022799,989
Peetz ChristopherDirector09/23/202119,323
CONWAY ROBERT EDirector09/23/2021151,153
CONWAY ROBERT EDirector09/23/2021151,153
Peetz ChristopherDirector09/23/202119,323
CONWAY ROBERT EDirector09/21/202197,966
ORBIMED ADVISORS LLCDirector09/17/20219,499,987
Decheng Capital China Life Sciences USD Fund III, L.P.10% Owner09/17/202114,499,998
Thompson Peter A.Director09/17/20219,499,987
Alpine ImmunoSciences, L.P.10% Owner09/17/20213,760,000
GOLD MITCHELLExecutive Chairman and CEO09/17/2021452,964
GOLD MITCHELLExecutive Chairman and CEO09/17/20213,760,000
Venkatesan JayDirector09/17/20213,760,000
Cui XiangminDirector09/17/202114,499,998
GOLD MITCHELLExecutive Chairman and CEO09/15/202134,840
GOLD MITCHELLExecutive Chairman and CEO09/16/202167,696
GOLD MITCHELLExecutive Chairman and CEO06/28/202134,792
GOLD MITCHELLExecutive Chairman and CEO06/25/202194,865
GOLD MITCHELLExecutive Chairman and CEO05/20/202118,316
GOLD MITCHELLExecutive Chairman and CEO05/19/2021765,917
Venkatesan JayDirector03/31/202127,718
Venkatesan JayDirector03/30/202131,289
GOLD MITCHELLExecutive Chairman and CEO04/14/2021105,200
GOLD MITCHELLExecutive Chairman and CEO04/13/2021100,714
GOLD MITCHELLExecutive Chairman and CEO03/05/2021129,875
GOLD MITCHELLExecutive Chairman and CEO03/04/2021130,108
GOLD MITCHELLExecutive Chairman and CEO02/02/2021117,381
GOLD MITCHELLExecutive Chairman and CEO02/01/2021128,665
PENG STANFORD LSee Remarks12/31/202049,430
GOLD MITCHELLExecutive Chairman and CEO12/31/2020140,150
Rickey James PaulSenior VP and CFO12/31/202028,451
ORBIMED ADVISORS LLCDirector12/28/20208,550,000
Thompson Peter A.Director12/28/20208,550,000
CONWAY ROBERT EDirector11/19/202080,300
Rickey James PaulSenior VP and CFO06/30/202021,925
GOLD MITCHELLExecutive Chairman and CEO06/30/202079,884
PENG STANFORD LSee Remarks06/30/202038,092
Rickey James PaulSenior VP and CFO05/30/201949,500
TIGER MANAGEMENT L.L.C.10% Owner02/08/2019146,245
Cui XiangminDirector01/18/201916,999,997
Thompson Peter A.Director01/18/20191,999,997
ORBIMED ADVISORS LLCDirector01/18/20191,999,997
Alpine ImmunoSciences, L.P.10% Owner01/18/20191,024,999
GOLD MITCHELLExecutive Chairman and CEO01/18/20191,024,999
Venkatesan JayDirector01/18/20191,024,999
Frazier Life Sciences VIII, L.P.10% Owner01/18/20191,999,997
Topper James NDirector01/18/20191,999,997
BVF PARTNERS L P/IL10% Owner06/20/201740,064
BVF PARTNERS L P/IL10% Owner06/07/201784,180
BVF PARTNERS L P/IL10% Owner06/05/201781,889
BVF PARTNERS L P/IL10% Owner05/31/201763,141
BVF PARTNERS L P/IL10% Owner05/30/201743,389
BVF PARTNERS L P/IL10% Owner05/17/201785,907
BVF PARTNERS L P/IL10% Owner05/19/201726,680
BVF PARTNERS L P/IL10% Owner05/18/201768,732
BVF PARTNERS L P/IL10% Owner05/11/201716,480
BVF PARTNERS L P/IL10% Owner05/10/2017145,433
BVF PARTNERS L P/IL10% Owner05/09/201791,516
CONWAY ROBERT EDirector05/08/201734,200
CONWAY ROBERT EDirector05/09/201711,700
TROHA JANICEExec Vice President / COO05/05/201723,400
CONWAY ROBERT EDirector05/05/201746,000
CONWAY ROBERT EDirector05/04/201722,600
Rodman David MalcomExec Vice President and CMO01/04/201715,179
Carruthers R MichaelExec Vice President / CFO12/02/201650,256
Rodman David MalcomExec Vice President and CMO10/04/201646,327
Rodman David MalcomExec Vice President and CMO07/05/201627,727
Congleton JonPresident and CEO06/16/201619,345
Congleton JonPresident and CEO03/24/201621,084
Congleton JonPresident and CEO03/22/201621,907
Congleton JonPresident and CEO12/11/201540,500
CONWAY ROBERT EDirector12/09/201581,000
Flynn James E10% Owner06/23/20151,085,546
Flynn James E10% Owner06/23/2015947,324
Flynn James E10% Owner06/23/20151,467,130
Rock Springs Capital Management LP10% Owner06/22/20152,800,000
Hawkes Bay Master Investors (Cayman) L.P.10% Owner06/22/201581,113
Hawkes Bay Master Investors (Cayman) L.P.10% Owner06/19/2015171,591
Jennison Global Healthcare Master Fund, Ltd.10% Owner06/22/20154,250,834
Jennison Global Healthcare Master Fund, Ltd.10% Owner06/17/2015366,086
Hawkes Bay Master Investors (Cayman) L.P.10% Owner06/18/201591,450
Hawkes Bay Master Investors (Cayman) L.P.10% Owner06/17/2015203,825
Load More Insider Transactions
FUNDS WITH A POSITION IN ALPINE IMMUNE SCIENCES INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
RA CAPITAL MANAGEMENT, L.P.4,909,7631.46%ExitedOther
BLACKROCK INC.3,575,0920.0033%16.89%Other
ORBIMED ADVISORS LLC2,680,4961.95%5.73%Other
GEODE CAPITAL MANAGEMENT, LLC910,5990.00334%19.13%Other
VIVO CAPITAL, LLC520,5051.63%-36.47%Other
ADAGE CAPITAL PARTNERS GP, L.L.C.310,0000.02%-56.62%Other
CANDRIAM S.C.A.415,0000.11%-11.7%Other
D. E. SHAW & CO., INC.428,5550.01%45.01%Other
BALYASNY ASSET MANAGEMENT L.P.372,9950.03%NewEvent Driven
RENAISSANCE TECHNOLOGIES LLC244,9810.02%13.06%Other
BAKER BROS. ADVISORS LP81,5780.04%NewOther
TUDOR INVESTMENT CORP ET AL50,7290.01%NewEvent Driven, Other
ALPS ADVISORS INC46,2220.01%16.75%Other
AQR CAPITAL MANAGEMENT LLC18,0790.00122%-32.97%Other
DRIEHAUS CAPITAL MANAGEMENT LLC23,5660.00931%No changeGrowth
GOTHAM ASSET MANAGEMENT, LLC8,7730.00525%NewOther
FARALLON CAPITAL MANAGEMENT LLC5,9000.00106%NewEvent Driven, Value
CHANGE IN SHARES OUTSTANDING FOR ALPINE IMMUNE SCIENCES INC
STOCK BUYBACKS FOR ALPINE IMMUNE SCIENCES INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
12.03%
1Q
12/31/2023
06/30/2023
14.76%
2Q
12/31/2023
03/31/2023
15.92%
3Q
12/31/2023
12/31/2022
41.17%
4Q
12/31/2023
09/30/2022
74.64%
5Q
12/31/2023
06/30/2022
81.84%
6Q
12/31/2023
03/31/2022
82.18%
7Q
12/31/2023
12/31/2021
87.58%
8Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
12.03%
1Q
06/30/2023
14.76%
2Q
03/31/2023
15.92%
3Q
12/31/2022
41.17%
4Q
09/30/2022
74.64%
5Q
06/30/2022
81.84%
6Q
03/31/2022
82.18%
7Q
12/31/2021
87.58%
8Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ALPINE IMMUNE SCIENCES INC
LOADING...